Cleared Traditional

K131266 - TREZ_HD (FDA 510(k) Clearance)

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K131266 · Excel-Tech Ltd. (Xltek) · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2014
Decision
287d
Days
Class 2
Risk

K131266 is an FDA 510(k) clearance for the TREZ_HD. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Excel-Tech Ltd. (Xltek) (Oakville, CA). The FDA issued a Cleared decision on February 14, 2014 after a review of 287 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Excel-Tech Ltd. (Xltek) devices

Submission Details

510(k) Number K131266 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 2013
Decision Date February 14, 2014
Days to Decision 287 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
139d slower than avg
Panel avg: 148d · This submission: 287d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 187
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K131266.
New Wave System
K260455 · Zeto, Inc. · Mar 2026
Flexset System
K233403 · Zeto, Inc. · Apr 2024
Neuronaute Plus
K231366 · Bioserenity Sas · Nov 2023
Q21
K221959 · Neurofield, Inc. · Aug 2023
SPARK Scan
K231457 · Spark Neuro, Inc. · Aug 2023
Cumulus Functional Neurophysiology Platform
K221963 · Cumulus Neuroscience Limited · Apr 2023